AI-Powered Innovation and Breakthroughs: AI Medical Imaging Forum Successfully Concludes
On the afternoon of May 8, the AI Medical Imaging Forum, part of the 8th Future Healthcare Ecosystem Expo, successfully concluded at the Beijing Beiren Yichuang International Convention and Exhibition Center. Distinguished guests, including Liu Shiyuan, Director of the Department of Radiology at Shanghai Changzheng Hospital and Chairman of the Chinese Society of Radiology; Fu Shinong, Founder and CEO of Synovate Technology (Beijing) Co., Ltd.; Duan Qi, Senior Director at SenseTime Group; Xu Chenyang, IEEE Fellow, President and Chairman of BVMedical, and Dean of the Chenuo Investment Industrial Research Institute; Gong Enhao, Founder and CEO of DeepWisdom Medicine; Zheng Han, Co-CEO and R&D Director at Shenzhen Anjian Technology Co., Ltd.; Ma Luna, Director of PanView Medical Beijing Center; Zhang Mengru and Wang Hao, Partners at LeLi Capital; Yu Xiaopeng, CEO of Neusoft Zhirui; Chen Gang, General Manager of Pengjian Medical and Founder and General Manager of Meiweida Medical; and Luo Jie, Founder and General Manager of Shansiwei, gathered to share insights and discuss hot topics such as the reshaping of the future landscape of medical imaging by AI technologies, practical applications of the integrated development of AI and imaging, and the empowerment of industrial growth through AI. The forum received strong support from LeLi Capital.
The forum officially commenced under the moderation of Zhang Mengru, Partner at Le Li Capital.
The first speaker to share on the topic isLiu Shiyuan, Director of the Department of Radiology at Shanghai Changzheng Hospital and Chairman of the Chinese Society of Radiology. He is at"AI Empowerment Across the Entire Workflow of Medical Imaging"In his thematic presentation, he elaborated in detail on the integration and empowerment of artificial intelligence across three key stages of the medical imaging workflow: image acquisition, image processing, and imaging diagnosis. “AI holds significant promise throughout the entire patient care journey, whether in the acquisition phase, image optimization phase, diagnostic phase, or overall patient management.” He expressed anticipation for further breakthroughs in AI-driven medical imaging in the future.
Liu Shiyuan, Director of the Department of Radiology at Shanghai Changzheng Hospital and Chairman of the Chinese Society of Radiology
Fu Shinong, Founder and CEO of Sinovision Technologies (Beijing) Co., Ltd.Shared with the audience"Intelligent Specialized CT Empowering High-Quality Development of Medical Imaging"Keynote Address. He argued that specialized CT products offer high added value and can genuinely help clinicians address clinical pain points and challenges. Directions for the specialization of CT include weight-bearing scans in orthopedics, providing real-time intraoperative imaging for surgical procedures, and offering more convenient interventional guidance for the interventional radiology department. He noted that achieving intelligent specialization in CT will face challenges such as precisely identifying clinical needs, rationally acquiring datasets, and solving technical problems through interdisciplinary collaboration.
Fu Shinong, Founder and CEO of Sinovision Technologies (Beijing) Co., Ltd.
Duan Qi, Senior Director of SenseTime GroupIn“Innovative Practices in Smart Hospital Construction Driven by Large Language Models”As introduced, SenseTime leverages its suite of multimodal foundational models for medical imaging to empower intelligent diagnosis and treatment, clinical research, and regional healthcare standardization, thereby facilitating the comprehensive upgrading of smart hospitals. Through collaborations with institutions such as Shanghai Ruijin Hospital, Macau Kiang Wu Hospital, the First Affiliated Hospital of Zhengzhou University, and the Qingdao West Coast New Area, as well as regional medical consortia, in areas including the construction of intelligent imaging platforms and smart healthcare cloud platforms, SenseTime is continuously deepening innovative practices in large-model-driven smart hospital development, enabling the practical application of new-quality productive forces in the healthcare sector.
Duan Qi, Senior Director of SenseTime Group
IEEE Fellow, President and Chairman of Bosh Medical, and Dean of the Xenuo Investment Industry Research Institute, Xu ChenyangShared at the forum a presentation titled"Smart Cancer Fighting, Building the Future: The Integration Journey of AI Medical Technology and Global Innovation Ecosystem"keynote address. He began with the history of humanity’s fight against cancer, citing atrial fibrillation treatment as an example, and proposed that intelligent cancer care requires deep collaboration among leaders from enterprises, hospitals, and universities. Breakthroughs are also needed in advanced technologies, medical-engineering translation capabilities, funding, and business models. He expressed hope that, by leveraging joint innovation consortia integrating AI and healthcare, the world can overcome its fear of cancer and save more lives of cancer patients.
IEEE Fellow, President and Chairman of Bosh Medical, and Dean of the Xeno Investment Industrial Research Institute, Xu Chenyang
Gong Enhao, Founder and CEO of DeepWisdom MedicalShared with the audience“Clinical Applications and Commercial Exploration of Generative AI-Driven Intelligent Imaging”“From imaging equipment, contrast agents, and services to applications, identifying breakthroughs to address issues at the data source, enhancing efficiency, and improving data quality represent the major trend toward AI-driven, end-to-end intelligent upgrading of the medical imaging industry,” he stated. DeepWise Medical leverages AI at the data layer as its entry point, utilizing artificial intelligence and generative models to significantly enhance data quality. By optimizing everything from equipment and contrast agents to workflows, the company delivers commercial value through cost reduction and efficiency gains.
Gong Enhao, Founder and CEO of DeepWisdom AI Medical
Zheng Han, Co-CEO and R&D Director of Shenzhen Anjian Technology Co., Ltd.At“Introduction to Advanced X-ray Imaging Technologies and Development Trends Based on AI Artificial Intelligence Technology”It is mentioned that, with the widespread adoption of AI technology, general radiography equipment has evolved in six directions: dynamic imaging, three-dimensional (3D) visualization, functional imaging, spectral imaging, low-dose radiation, and portability. The combination of AI-based intelligent recognition and dynamic radiography provides more effective clinical data to support precise diagnosis and treatment. Leveraging AI technology, Shenzhen Angel Medical Technology has developed innovative products capable of 3D scanning and imaging on general radiography platforms, including digital radiography (DR) systems with 3D capabilities, dynamic DR, and cold cathode X-ray sources.
Zheng Han, Co-CEO and R&D Director of Shenzhen Anjian Technology Co., Ltd.
In"Opportunities and Challenges for Independent Imaging Centers"In China,Ma Luna, Director of the Beijing Center of Panorama Medical ImagingShe shared the opportunities and challenges faced by independent imaging centers against the backdrop of AI technological advancements. “Independent imaging centers serve as a specialized supplement to public hospitals,” she summarized. Third-party medical imaging centers are continuously innovating and upgrading across multiple dimensions—including scientific research, talent development, equipment, services, and AI applications—to enhance the quality of differentiated medical services, alleviate the difficulties of accessing care and long waiting times, and meet patients’ urgent needs.
Ma Luna, Dean of Panorama Medical Beijing Center
Zhang Mengru, Partner at Leli CapitalIn"Medical Imaging and the Development of Primary Healthcare Systems"In his keynote address, he outlined how medical imaging technology empowers the high-quality development and service capabilities of primary healthcare institutions from four perspectives. He noted that primary care faces challenges such as shortages of physicians, equipment, and clinical experience, coupled with a heavy healthcare burden. Therefore, leveraging AI to advance inclusive healthcare means more precise diagnostics and treatment at lower costs. “We aspire to achieve more precise and cost-effective production and sales of medical devices, enabling better diagnostic and therapeutic methods to reach every county and village in China, a country with a population of 1.4 billion,” he said.
Zhang Mengru, Partner at Leli Capital
During the roundtable discussion titled “How Will AI Empower the Development of Medical Imaging?”Yu Xiaopeng, CEO of Neusoft Zhirui; Chen Gang, General Manager of Pengjian Medical and Founder and General Manager of Meiweida Medical; Luo Jie, Founder and General Manager of Shansiwei; and Ma Luna, Director of the Beijing Center of Panorama Medical Imaging,Roundtable Moderator,LeLi CapitalPartner Wang HaoUnder the moderation, participants engaged in insightful discussions on topics such as the new changes generative AI will bring to medical imaging, the opportunities and challenges facing AI-powered medical imaging products in deepening their applications, and the efforts required to deploy AI medical imaging solutions to primary care settings for assisted diagnosis and treatment. All attendees agreed that the future development of AI in medical imaging presents both challenges and opportunities. Chinese medical imaging companies need to further strengthen collaboration among industry, academia, research institutions, and healthcare providers, continuously iterate and upgrade core technologies, innovate more scenarios integrating AI with imaging, proactively lay out next-generation technologies, and seize opportunities across both high-end products and the primary care market.
From left to right: Wang Hao, Partner at Leli Capital; Yu Xiaopeng, CEO of Neusoft Zhirui; Chen Gang, General Manager of Pengjian Medical and Founder & General Manager of Meiweida Medical; Luo Jie, Founder & General Manager of Shansiwei; and Ma Luna, Dean of the Beijing Center of Panorama Medical Imaging.